Official recall notice

FDA DrugClass INotable

Kian Pee Wan Capsules Recall (Aug 2026) – Buy-Herbal

Product: Kian Pee Wan Capsules, 30-count bottles

Recall date
2026-08-19
Category
Drug
FDA class
Class I

Why it was recalled

Hazard

Marketed Without an Approved NDA/ANDA: Product contains undeclared drug ingredients dexamethasone and cyproheptadine.

One email a week when there are new recalls. Confirm by email; unsubscribe anytime.

Product description

Marketed Without an Approved NDA/ANDA: Product contains undeclared drug ingredients dexamethasone and cyproheptadine.

Affected products

All lots within expiry.

Verify with the official notice →
Share:

Related Recalls

2026-10-09 · FDA_DRUG
FDA Recall: Par Pharmaceutical: Brevital Sodium 500 mg/vial for Injection
Par Pharmaceutical
2026-10-01 · FDA_DRUG
FDA Recall: Greenwich: Glutathione Injection
Greenwich
2026-10-01 · FDA_DRUG
FDA Recall: Greenwich: Glutathione Injection
Greenwich
2026-09-30 · FDA_DRUG
FDA Recall: Reliable -1 Laboratories, Sodium Chloride Hypertonicity Ophthalmic Solution, 5%, Sterile, 0.5 FL OZ
Sterling Pharmaceutical Services LLC